CLRB - 2.08 Pre-market now at 2.30/2.38 Cellectar Biosciences Receives Japanese Patent for CLR 131 and CLR 125 for the Treatment of Cancer Stem Cells http://stockcharts.com/c-sc/sc?s=CLRB&p=D&b=5&g=0&i=t85007954138&r=1492519161651 http://stockcharts.com/c-sc/sc?s=CLRB&p=W&b=5&g=0&i=t42658896801&r=1492519142115